The U.S. Food and Drug Administration (FDA) has approved Valtoco® (diazepam nasal spray). This is a new seizure medicine designed to treat periods of frequent seizures or cluster seizures that are distinct from the person’s usual seizure pattern....
On January 10, 2020, the U.S. Food and Drug Administration (FDA) published a company alert about a voluntary recall of lamotrigine 100 mg tablets from Taro Pharmaceuticals.
Lamotrigine 100 mg tablets from lot # 331771 are being recalled due to...
Webinar on Thursday, February 6, 2020, 2:00 to 3:00 p.m. ET
Register here
Download the Webinar Flyer
Feb 2020 Webinar on Cognitive Behavioral Therapy in Epilepsy
Please join us for a webinar hosted by the National Association of...
Originally published June 4, 2019
The following series of webinars was developed to increase understanding among neuroscience nurses about epilepsy, seizure emergencies, comorbidities, and sudden unexpected death in epilepsy (SUDEP). The webinars...
Sam De Brouwer is the co-founder of doc.ai. Recently, doc.ai launched an epilepsy digital health trial to test how artificial intelligence (A.I.) might be able to help identify the right treatment for the right person at the right time. We sat down...
